Showing results (51-60 of 206) with videos related to

Sort By:
Pageof 21
Arthritis Research & Therapy|September 14, 2013
Predicting persistent inflammatory arthritis amongst early arthritis clinic patients in the UK: is musculoskeletal ultrasound required?Arthur G Pratt, Alice R Lorenzi, Gill Wilson, et al.
Nature Reviews. Drug Discovery|August 22, 2015
Why is it hard to terminate failing projects in pharmaceutical R&D?Richard W Peck, Dennis W Lendrem, Iain Grant, et al.
Nature Reviews. Rheumatology|February 21, 2023
Rheumatoid sarcopenia: loss of skeletal muscle strength and mass in rheumatoid arthritisJoshua L Bennett, Arthur G Pratt, Richard Dodds, et al.
Immunotherapy Advances|December 25, 2025
A phase 1 experimental medicine study of anti-CD3 monoclonal antibody in rheumatoid arthritisCatherine A Lawson, Rachel Harry, Bridget Griffiths, et al.
RMD Open|April 1, 2025
Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritisLeher Gumber, Fiona Rayner, Theophile Bigirumurame, et al.
Rheumatology (Oxford, England)|July 5, 2016
Components of treatment delay in rheumatoid arthritis differ according to autoantibody status: validation of a single-centre observation using national audit dataArthur G Pratt, Dennis Lendrem, Ben Hargreaves, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammationSimi Ali, Helen Robertson, Julie H Wain, et al.
Rheumatology (Oxford, England)|July 24, 2021
Predictors of poor function in RA based on two prospective UK inception cohorts. Do comorbidities matter?Amanda D Busby, James Wason, Arthur G Pratt, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 14, 2019
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory DocumentsVibeke Strand, Joao Gonçalves, Timothy P Hickling, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 28, 2020
Correction to: Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory DocumentsVibeke Strand, Joao Gonçalves, Timothy P Hickling, et al.
Pageof 21